Metabolomics, microbiota, and in vivo and in vitro biomarkers in type 2 severe asthma: a perspective review

HIGHLIGHTS

• who: Cristiano Caruso and colleagues from the Allergy Unit, Fondazione Policlinico AGemelli, Catholic University of the Sacred Heart, UniCamillus, Saint Camillus International, University of Health Sciences, Rome, Italy have published the paper: Metabolomics, Microbiota, and In Vivo and In Vitro Biomarkers in Type 2 Severe Asthma: A Perspective Review, in the Journal: Metabolites 2021, 11, 647. of /2021/
• what: Metabolomics has already been successfully applied in various fields of science, showing promise in maintaining safety and efficacy in clinical real-life research.
• how: In this review the authors described asthma omics fields (genomics . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.